State of Michigan Retirement System Grows Stock Holdings in Hims & Hers Health, Inc. $HIMS

State of Michigan Retirement System grew its holdings in shares of Hims & Hers Health, Inc. (NYSE:HIMS) by 84.9% in the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned 1,379,100 shares of the company’s stock after purchasing an additional 633,300 shares during the period. State of Michigan Retirement System’s holdings in Hims & Hers Health were worth $68,748,000 as of its most recent SEC filing.

Other large investors have also recently made changes to their positions in the company. Quaker Wealth Management LLC purchased a new position in shares of Hims & Hers Health during the second quarter valued at approximately $29,000. Bessemer Group Inc. lifted its holdings in shares of Hims & Hers Health by 105.8% during the second quarter. Bessemer Group Inc. now owns 607 shares of the company’s stock valued at $30,000 after purchasing an additional 312 shares during the last quarter. Geneos Wealth Management Inc. purchased a new position in shares of Hims & Hers Health during the first quarter valued at approximately $30,000. BI Asset Management Fondsmaeglerselskab A S purchased a new position in Hims & Hers Health in the 1st quarter worth approximately $41,000. Finally, Larson Financial Group LLC raised its holdings in Hims & Hers Health by 47.7% in the 1st quarter. Larson Financial Group LLC now owns 1,419 shares of the company’s stock worth $42,000 after acquiring an additional 458 shares during the last quarter. 63.52% of the stock is currently owned by hedge funds and other institutional investors.

Hims & Hers Health Price Performance

Shares of HIMS opened at $45.55 on Friday. The firm has a market cap of $10.30 billion, a PE ratio of 56.94, a P/E/G ratio of 3.15 and a beta of 2.25. The company has a current ratio of 4.98, a quick ratio of 4.46 and a debt-to-equity ratio of 1.72. The firm has a fifty day simple moving average of $51.39 and a two-hundred day simple moving average of $50.44. Hims & Hers Health, Inc. has a 1-year low of $18.33 and a 1-year high of $72.98.

Hims & Hers Health (NYSE:HIMS) last announced its earnings results on Monday, August 4th. The company reported $0.17 earnings per share for the quarter, missing analysts’ consensus estimates of $0.18 by ($0.01). The company had revenue of $544.83 million for the quarter, compared to analysts’ expectations of $550.06 million. Hims & Hers Health had a net margin of 9.63% and a return on equity of 26.26%. Hims & Hers Health’s quarterly revenue was up 72.6% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.06 earnings per share. Hims & Hers Health has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS. On average, equities analysts anticipate that Hims & Hers Health, Inc. will post 0.29 EPS for the current year.

Wall Street Analyst Weigh In

A number of brokerages recently weighed in on HIMS. Wall Street Zen lowered shares of Hims & Hers Health from a “buy” rating to a “hold” rating in a report on Monday, July 28th. Weiss Ratings restated a “hold (c+)” rating on shares of Hims & Hers Health in a report on Tuesday, October 14th. Canaccord Genuity Group restated a “buy” rating and issued a $68.00 price objective on shares of Hims & Hers Health in a report on Friday, September 12th. Zacks Research lowered shares of Hims & Hers Health from a “strong-buy” rating to a “hold” rating in a report on Tuesday, August 19th. Finally, Truist Financial decreased their price objective on shares of Hims & Hers Health from $48.00 to $37.00 and set a “hold” rating for the company in a report on Monday, August 18th. Two research analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and three have assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Reduce” and an average target price of $38.92.

Insider Buying and Selling at Hims & Hers Health

In other news, insider Michael Chi sold 900 shares of the company’s stock in a transaction on Friday, October 10th. The stock was sold at an average price of $58.25, for a total value of $52,425.00. Following the completion of the sale, the insider directly owned 291,439 shares in the company, valued at $16,976,321.75. This represents a 0.31% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, CFO Oluyemi Okupe sold 11,592 shares of the company’s stock in a transaction on Friday, October 17th. The stock was sold at an average price of $57.13, for a total value of $662,250.96. Following the completion of the sale, the chief financial officer owned 70,232 shares of the company’s stock, valued at $4,012,354.16. This trade represents a 14.17% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders sold 1,432,271 shares of company stock worth $74,229,585. Insiders own 13.71% of the company’s stock.

About Hims & Hers Health

Hims & Hers Health, Inc operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.